Document Detail

New medications for substance use disorders: challenges and opportunities.
MedLine Citation:
PMID:  22157859     Owner:  NLM     Status:  MEDLINE    
An increased understanding of the biological mechanisms underlying the process of addiction has led to unique molecular targets and strategies for pharmacotherapies against addiction. However, the successful translation of these discoveries will require: 1) a more active engagement of the pharmaceutical sector, 2) partnership with regulatory agencies to arrive at meaningful outcomes for medication approval and 3) a greater involvement of the healthcare system in the screening and treatment of substance use disorders.
Nora D Volkow; Phil Skolnick
Related Documents :
23965369 - Diverse challenges in pediatric compounding: treating pulmonary hypertension, uncombabl...
22239329 - Maximising medicine through aphorisms.
21606849 - Role of medical surveillance in risk management.
21597999 - Effectiveness of medical equipment donations to improve health systems: how much medica...
8898269 - Screening for hearing loss in juvenile detention centers.
22197799 - Using incentives to reduce substance use and other health risk behaviors among people w...
21212919 - Control of intravenous medication wastage at a teaching hospital in saudi arabia.
20881829 - Economic impact of a primary care career: a harsh reality for medical students and the ...
24007889 - Requirements for medication monitoring in assisted living facilities.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology     Volume:  37     ISSN:  1740-634X     ISO Abbreviation:  Neuropsychopharmacology     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-14     Completed Date:  2012-08-21     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  8904907     Medline TA:  Neuropsychopharmacology     Country:  England    
Other Details:
Languages:  eng     Pagination:  290-2     Citation Subset:  IM    
National Institute on Drug Abuse, Bethesda, MD 20892, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Design*
National Institutes of Health (U.S.) / trends*
Psychopharmacology / trends*
Substance-Related Disorders / drug therapy*
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neuroscience networking: linking discovery to drugs.
Next Document:  Effect of Ankle Braces on Lower Extremity Joint Energetics in Single-Leg Landings.